Clinical Trials
9 trialsNCT07480733 2026-05-29
Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Recruiting
NCT06499350 2026-03-10
A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase 1/2 Recruiting
NCT07292402 2025-12-23
JSKN022 in Subjects With Advanced Malignant Solid Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1 Recruiting
NCT05749627 2025-02-27
Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors
The First Affiliated Hospital of Nanchang University
Phase NA Recruiting
NCT06571422 2025-02-21
Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Recruiting
NCT06464055 2025-02-10
A Study of GQ1010 in Subjects With Advanced Solid Tumors
GeneQuantum Healthcare (Suzhou) Co., Ltd.
Phase 1/2 Recruiting
NCT06728189 2024-12-11
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors
Peking University Cancer Hospital & Institute
Phase 1 Recruiting
NCT05773937 2024-09-19
A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1 Recruiting
NCT05886374 2023-07-21
A Study of HMPL-415S1 in Patients With Advanced Malignant Solid Tumors
Hutchmed
Phase 1 Recruiting